Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lipocine (LPCN) Restructuring Costs (2016 - 2021)

Historic Restructuring Costs for Lipocine (LPCN) over the last 4 years, with Q2 2021 value amounting to $4.0 million.

  • Lipocine's Restructuring Costs changed N/A to $4.0 million in Q2 2021 from the same period last year, while for Dec 2021 it was $4.0 million, marking a year-over-year change of. This contributed to the annual value of $4.0 million for FY2021, which is N/A changed from last year.
  • Lipocine's Restructuring Costs amounted to $4.0 million in Q2 2021.
  • Lipocine's 5-year Restructuring Costs high stood at $4.0 million for Q2 2021, and its period low was $4.0 million during Q2 2021.